Terms: = Germ cell tumor AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Prognosis
25 results:
1. Correlations between the expression of molecules in the TGF-β signaling pathway and clinical factors in adamantinomatous craniopharyngiomas.
Jin L; Cai K; Wu W; Xiao Y; Qiao N; Liu F; Ru S; Cao L; Zhu H; Bai J; Liu C; Li C; Zhao P; Zhang Y; Gui S
Front Endocrinol (Lausanne); 2023; 14():1167776. PubMed ID: 37854185
[TBL] [Abstract] [Full Text] [Related]
2. A preliminary study on the mechanism of VASH2 in childhood medulloblastoma.
Liu W; Fu Y; Wang M; Zhao J; Chen J; Wang Y; Qin H
Sci Rep; 2023 Oct; 13(1):17153. PubMed ID: 37821528
[TBL] [Abstract] [Full Text] [Related]
3. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling.
Feng F; Zhao Z; Cai X; Heng X; Ma X
Cancer Med; 2023 Mar; 12(5):5889-5907. PubMed ID: 36284444
[TBL] [Abstract] [Full Text] [Related]
4. Paradoxical role of β8 integrin on angiogenesis and vasculogenic mimicry in glioblastoma.
Liu Y; Xu X; Zhang Y; Mo Y; Sun X; Shu L; Ke Y
Cell Death Dis; 2022 Jun; 13(6):536. PubMed ID: 35676251
[TBL] [Abstract] [Full Text] [Related]
5. Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/smad2/3-Snail/ZEB1 signaling pathway.
Zhu M; Niu J; Jiang J; Dong T; Chen Y; Yang X; Liu P
Life Sci; 2022 Mar; 293():120358. PubMed ID: 35092731
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA SND1-IT1 accelerates cell proliferation, invasion and migration via regulating miR-132-3p/smad2 axis in retinoblastoma.
Yin DF; Zhou XJ; Li N; Liu HJ; Yuan H
Bioengineered; 2021 Dec; 12(1):1189-1201. PubMed ID: 34969359
[TBL] [Abstract] [Full Text] [Related]
7. Upregulation of Epithelial-To-Mesenchymal Transition Markers and P2X7 Receptors Is Associated to Increased Invasiveness Caused by P2X7 Receptor Stimulation in Human Glioblastoma Stem cells.
Ziberi S; Zuccarini M; Carluccio M; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Di Iorio P; Ciccarelli R
Cells; 2019 Dec; 9(1):. PubMed ID: 31905754
[TBL] [Abstract] [Full Text] [Related]
8. Identification of novel LncRNA targeting smad2/PKCα signal pathway to negatively regulate malignant progression of glioblastoma.
Tang C; Wang Y; Zhang L; Wang J; Wang W; Han X; Mu C; Gao D
J Cell Physiol; 2020 Apr; 235(4):3835-3848. PubMed ID: 31603255
[TBL] [Abstract] [Full Text] [Related]
9. An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma.
Morabito M; Larcher M; Cavalli FM; Foray C; Forget A; Mirabal-Ortega L; Andrianteranagna M; Druillennec S; Garancher A; Masliah-Planchon J; Leboucher S; Debalkew A; Raso A; Delattre O; Puget S; Doz F; Taylor MD; Ayrault O; Bourdeaut F; Eychène A; Pouponnot C
EMBO Mol Med; 2019 Aug; 11(8):e9830. PubMed ID: 31328883
[TBL] [Abstract] [Full Text] [Related]
10. HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
Li H; Li J; Chen L; Qi S; Yu S; Weng Z; Hu Z; Zhou Q; Xin Z; Shi L; Ma L; Huang A; Lu Y
Clin Cancer Res; 2019 Jun; 25(12):3602-3616. PubMed ID: 30862693
[TBL] [Abstract] [Full Text] [Related]
11. Maelstrom Directs Myeloid-Derived Suppressor cells to Promote Esophageal Squamous cell Carcinoma Progression via Activation of the Akt1/RelA/IL8 Signaling Pathway.
Li P; Chen X; Qin G; Yue D; Zhang Z; Ping Y; Wang D; Zhao X; Song M; Zhao Q; Li J; Liu S; Wang D; Zhang C; Lian J; Cao L; Li F; Huang L; Wang L; Yang L; Huang J; Li H; Zhang B; Zhang Y
Cancer Immunol Res; 2018 Oct; 6(10):1246-1259. PubMed ID: 30082413
[No Abstract] [Full Text] [Related]
12. The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study.
Sferra R; Pompili S; Festuccia C; Marampon F; Gravina GL; Ventura L; Di Cesare E; Cicchinelli S; Gaudio E; Vetuschi A
Eur J Histochem; 2017 May; 61(2):2732. PubMed ID: 28735518
[TBL] [Abstract] [Full Text] [Related]
13. CFC1 is a cancer stemness-regulating factor in neuroblastoma.
Chikaraishi K; Takenobu H; Sugino RP; Mukae K; Akter J; Haruta M; Kurosumi M; Endo TA; Koseki H; Shimojo N; Ohira M; Kamijo T
Oncotarget; 2017 Jul; 8(28):45046-45059. PubMed ID: 28620148
[TBL] [Abstract] [Full Text] [Related]
14. USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7.
Kit Leng Lui S; Iyengar PV; Jaynes P; Isa ZFBA; Pang B; Tan TZ; Eichhorn PJA
EMBO Rep; 2017 May; 18(5):797-808. PubMed ID: 28381482
[TBL] [Abstract] [Full Text] [Related]
15. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract] [Full Text] [Related]
16. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.
Fang L; Zhao J; Wang D; Zhu L; Wang J; Jiang K
Int J Mol Med; 2016 Jul; 38(1):172-82. PubMed ID: 27246838
[TBL] [Abstract] [Full Text] [Related]
17. Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration.
Mondal B; Patil V; Shwetha SD; Sravani K; Hegde AS; Arivazhagan A; Santosh V; Kanduri M; Somasundaram K
Oncogene; 2017 Jan; 36(1):71-83. PubMed ID: 27212030
[TBL] [Abstract] [Full Text] [Related]
18. Upregulation of p-smad2 contributes to FAT10-induced oncogenic activities in glioma.
Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
[TBL] [Abstract] [Full Text] [Related]
19. TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination.
Cantelli G; Orgaz JL; Rodriguez-Hernandez I; Karagiannis P; Maiques O; Matias-Guiu X; Nestle FO; Marti RM; Karagiannis SN; Sanz-Moreno V
Curr Biol; 2015 Nov; 25(22):2899-914. PubMed ID: 26526369
[TBL] [Abstract] [Full Text] [Related]
20. HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways.
Duan R; Han L; Wang Q; Wei J; Chen L; Zhang J; Kang C; Wang L
Oncotarget; 2015 Sep; 6(29):27778-93. PubMed ID: 26356815
[TBL] [Abstract] [Full Text] [Related]
[Next]